Back
Nemaura Medical 10K Form
Sell
38
NMRD
Nemaura Medical
Last Price:
0.04
Seasonality Move:
15.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-14 | 10Q | NMRD/Nemaura Medical Quarterly |
2020-06-29 | 10K | NMRD/Nemaura Medical Annual |
2020-02-10 | 10Q | NMRD/Nemaura Medical Quarterly |
2019-11-08 | 10Q | NMRD/Nemaura Medical Quarterly |
2019-08-09 | 10Q | NMRD/Nemaura Medical Quarterly |
2019-06-14 | 10K | NMRD/Nemaura Medical Annual |
Receive NMRD News And Ratings
See the #1 stock for the next 7 days that we like better than NMRD
NMRD Financial Statistics
Sales & Book Value
Annual Sales: | $77.04K |
---|---|
Cash Flow: | $-1.49M |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.62 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.39000 |
---|---|
Net Income (TTM): | $-10.65M |
Gross Margin: | $-1.48M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Nemaura Medical Earnings Forecast
Key Nemaura Medical Financial Ratios
- The Gross Profit Margin over the past 4 years for NMRD is -1,916.39%.
- The Selling, General & Administrative Expenses for NMRD have been equal to 7,269.20% of Gross Profit Margin.
- The Research & Development expenses have been 1,997.17% of Revenue.
- The Interest Expense is -45.34% of Operating Income.
- The Net Earning history of NMRD is -18,358.96% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 3 years.
Nemaura Medical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | NMRD |
CUSIP: | 640442 |
Website: | nemauramedical.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NMRD Technical Analysis vs Fundamental Analysis
Sell
38
Nemaura Medical (NMRD)
is a Sell
Is Nemaura Medical a Buy or a Sell?
-
Nemaura Medical stock is rated a Sell
The current Nemaura Medical [NMRD] share price is $0.04. The Score for NMRD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.